MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study
Authors:
- Martin KöhrmannMKMartin Köhrmann
- Eric JüttlerEJEric Jüttler
- Jochen B FiebachJFJochen B Fiebach
- Hagen B HuttnerHHHagen B Huttner
- Stefan SiebertSSStefan Siebert
- Christian SchwarkCSChristian Schwark
- Peter A RinglebPRPeter A Ringleb
- Peter D SchellingerPSPeter D Schellinger
- Werner HackeWHWerner Hacke
- 1 August 2006
- journal article
- clinical trial
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (8) , 661-667
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and SafeStroke, 2005
- Acute Hyperglycemia State Is Associated With Lower tPA-Induced Recanalization Rates in Stroke PatientsStroke, 2005
- Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection ProtocolStroke, 2005
- Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical PracticeStroke, 2003
- Beyond MismatchStroke, 2003
- Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic StrokeStroke, 2003
- Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 HoursStroke, 2002
- CT and Diffusion-Weighted MR Imaging in Randomized OrderStroke, 2002
- Magnetic Resonance Imaging Detection of Microbleeds Before ThrombolysisStroke, 2002
- Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen ActivatorStroke, 2001